COVID-19 vaccine planning
This is a centralized resource where you'll find everything you need to know to be ready to administer COVID-19 vaccine. We’ll regularly update this page as more information is available.
Social media resources
"I GOT MY COVID-19 VACCINE/RECIBÍ MI VACUNA CONTRA COVID-19"
Access all bulletins
Janssen COVID-19 vaccine
Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers
Janssen COVID-19 Fact Sheet for Patients
Fact Sheet on Vaccines and Fetal Cell Lines (Immunize Nevada)
Fact Sheet on Janssen Vaccine (Immunize Nevada)
ACIP Recommendation for Use of Janssen COVID-19 Vaccine
Janssen Vaccine Storage and Handling Summary
Janssen Vaccine Storage and Handling Labels
Transport Guidance Summary
Transport Temperature Log
Janssen Standing Orders
Janssen Training Module
Janssen Preparation and Administration Summary
Pfizer-BioNTech and Moderna resources
What Clinic Personnel Need to Know
Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines
Moderna COVID-19 vaccine
Moderna Vaccine Storage and Handling Summary
Moderna Training Module
Moderna Preparation and Administration Summary
Moderna Vaccine Lot 41L20A Technical Bulletin
Moderna COVID-19 Vaccine Information
Moderna COVID-19 Vaccine Standing Orders
Moderna COVID-19 Vaccine Fact Sheet for Healthcare Providers
Moderna COVID-19 Vaccine Fact Sheet for Patients
Moderna COVID-19 Vaccine Fact Sheet for Patients - Translation in 6 languages
Pfizer-BioNTech Storage and Handling Summary
Pfizer-BioNTech Training Module
Pfizer-BioNTech Preparation and Administration Summary
Pfizer- BioNTech Storage and Handling Checklist
Pfizer-BioNTech Vaccine Information
Pfizer-BioNTech Vaccine Standing Orders
Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers
Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Patients
Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Patients - Translation in 20 languages
COVID-19 Prevaccination Checklist
Long-Term Care Facility Toolkit: Preparing for COVID-19 Vaccination at Your Facility
CDC COVID-19 Vaccination Program Provider Requirements and Support
COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
10 Things Healthcare Professionals Need to Know
Hosting Mass Immunization Clinics
COVID-19 ACIP Vaccine Recommendations
VaccineFinder Reporting and Finder System
Answering Patients' Questions
Vaccine administration and other resources
Standing Orders and Screening Checklist
Satellite, Temporary, and Off-Site Vaccination Clinic Supply Checklist
Vaccine Storage and Handling with COVID-19 Vaccine Addendum
COVID-19 Vaccine Training Modules
Clinical Training and Resources for Healthcare Professionals
Fever and Vaccines
COVID-19 Vaccine Training through TRAIN
Vaccine Administration Job Aids
Billing and coding resources
Payor information for COVID-19 vaccine for immunocompromised individuals
COVID-19 Vaccine Toolkit for Health Insurance Issuers and Medicare Advantage Plan Payers (PDF)
COVID-19 Vaccine Policies and Guidance - CMS
CPT Code set for Coronavirus Immunizations
HRSA COVID-19 Claims Reimbursement - Uninsured Patient Program
Specific Insurance Plan Guidance
Frequently asked questions
What is the FDA’s role in approving vaccines and what is being done to produce a COVID-19 vaccine?
The FDA regulates vaccines. Vaccines undergo a rigorous review of laboratory and clinical data to ensure the safety and effectiveness of these products. Approved vaccines may also be required to undergo additional studies to further evaluate the vaccine and often to address specific questions about the vaccine's safety, effectiveness, or possible side effects. The FDA is expediting clinical trials for vaccines by providing timely advice to and interactions with vaccine developers. The FDA is also supporting product development and scaling up of manufacturing capacity for high priority vaccines for COVID-19.
How does a facility receive COVID-19 Vaccine distribution?
If you are interested in stocking and administering the COVID-19 vaccine and meet the requirements below, please fill out this survey https://www.surveymonkey.com/r/9VLNBGB
- You are enrolled in NV WEBIZ.
- You have a stand-alone freezer and a stand-alone refrigerator with digital temperature monitoring devices for vaccine storage.
How does a facility request a data logger?
If a facility needs a data logger, they should include their request in the REDCap enrollment survey. Requests for new data loggers may be submitted to email@example.com
How many doses of COVID-19 vaccine will be needed?
All but one of the COVID-19 vaccines currently in phase 3 clinical trials in the United States use two doses. The other COVID-19 vaccine uses one dose. When giving two doses, they are usually given one or two months apart. We will need to wait for the results of the clinical trials to have more information about how many doses will be needed.
How do we know the COVID-19 vaccine will be safe?
Independent advisory committees to the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) review vaccine safety and effectiveness data before any vaccine is approved or allowed for distribution under Emergency Use Authorization. Vaccines will not be released for use until deemed safe and effective by these committees. In order to speed up the distribution process, Operation Warp Speed is manufacturing vaccines while they are in clinical trials with the intention of throwing them away if the vaccine is not deemed safe and effective at the conclusion of the clinical trial.
Will COVID-19 vaccines contain a microchip?
COVID-19 vaccines will not contain microchips. This idea is based on a false narrative and misinformation campaign being waged online.
Will COVID-19 vaccines alter people’s DNA?
No. There is no evidence the vaccines would alter any part of your genomic DNA. These vaccines are “mRNA” vaccines, which use a fragment of genetic material from the virus rather than a weakened or killed version of the virus, to produce an immune response
Since this vaccine is producing an immune response, would someone who received the vaccine then also test positive for COVID-19?
No. A COVID-19 vaccine administration will NEVER yield a positive COVID PCR test result, regardless if a patient has a low-grade fever or not. The vaccine makes the muscle cells produce the spike protein and antibodies are formed to the spike protein. For a test to be positive, there must be viral RNA in the nose. The vaccine does not cause that.
How long is received vaccine viable for? Can vaccine vials be refrigerated after they have been thawed out?
Once vaccine vials have been pulled out of their Ultra-Cold Storage Units, they are viable for up to 5 days in refrigerators. The ultra-cold vaccine, Pfizer product, vials cannot be refrozen. They must only be thawed out with the intention of using them within 5 days of removal from the ultra-cold freezer. Once a vial has been diluted it must be used within 6 hours
How often must vaccination data be reported?
Vaccination data should ideally be reported within 24 hours, but no later than 72 hours.